Final Glance: Pharmaceuticals companies
AP - 2 hrs 59 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)
Final Glance: Medical Devices companies
AP - 2 hrs 59 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were up at the close of trading:
ZMH: 117.49 (+0.12), JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33)
15 'Sustainable' Companies Not Named Apple to Buy Right Now
at The Street - Wed Apr 22, 3:45PM CDT
American companies topped the list of global corporate sustainability leaders in 2015, but are they good investments? We take a look on earth day 2015.
KO: 41.31 (+0.53), BIIB: 423.57 (+1.46), ACT: 295.22 (+0.69), GE: 26.91 (+0.29), A: 42.71 (-0.18), INTC: 32.70 (+0.27), ADBE: 75.50 (+0.88), JNJ: 100.43 (+0.13), SIAL: 138.92 (+0.17), CPB: 46.11 (+0.06), GIS: 56.21 (+0.10), CSCO: 28.62 (-0.07), CL: 69.28 (+0.27), ECL: 116.05 (+0.17), JCI: 51.33 (+0.30)
The Fed And The Markets: Where To Invest In The Current Environment
Nicholas P. Cheer - at Seeking Alpha - Wed Apr 22, 1:08PM CDT
JNJ: 100.43 (+0.13), BIIB: 423.57 (+1.46), BOND: 109.71 (-0.57), USB: 42.83 (+0.33), GILD: 104.18 (-1.02), AIG: 56.58 (-0.06), AAPL: 128.62 (+1.71), TLT: 127.72 (-1.98)
Midday Glance: Pharmaceuticals companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)
Midday Glance: Medical Devices companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 117.49 (+0.12), JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33)
Johnson & Johnson to Host Pharmaceutical Business Review
M2 - Wed Apr 22, 10:38AM CDT
Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceutical business for the investment community beginning at 8:30 a.m. (Eastern Time) on Wednesday, May 20, 2015 at the Hyatt Regency Hotel in New Brunswick, New Jersey and ending at approximately 3:00 p.m.
JNJ: 100.43 (+0.13)
Early Glance: Pharmaceuticals companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)
Early Glance: Medical Devices companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 117.49 (+0.12), JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33)
The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:30AM CDT
The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals
JNJ: 100.43 (+0.13), BIIB: 423.57 (+1.46), GILD: 104.18 (-1.02), ANTH: 4.79 (+0.10), GERN: 4.20 (-0.04)
Gilead Sciences Vs. AbbVie: Which Is A Better Buy?
Mycroft - at Seeking Alpha - Wed Apr 22, 7:49AM CDT
JNJ: 100.43 (+0.13), ABT: 48.35 (+1.23), PCYC: 256.98 (-0.77), GILD: 104.18 (-1.02), SHPG: 253.58 (+3.70), ABBV: 64.52 (+0.91)
Asian stocks mostly higher as Japan exports improve
By YURI KAGEYAMA - AP - Tue Apr 21, 10:35PM CDT
TOKYO (AP) — Asian stocks were mostly higher Wednesday after Japan reported its first trade surplus in three years, adding optimism to regional sentiment despite a fall on Wall Street.
JNJ: 100.43 (+0.13), UTX: 116.96 (+0.01), DD: 71.44 (+0.75)
Pharmacyclics Announces Positive Results on Imbruvica - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 4:54PM CDT
Pharmacyclics (PCYC) announced positive long-term follow-up data on Imbruvica.
BIIB: 423.57 (+1.46), JNJ: 100.43 (+0.13), PCYC: 256.98 (-0.77), ABBV: 64.52 (+0.91)
3 Things to Know About Apple and IBM's Most Recent Cloud Computing Innovation
Andrew Tonner, The Motley Fool - Motley Fool - Tue Apr 21, 1:03PM CDT
IBM's and Apple's CEOs. Image source: IBM Beyond plenty of publicity, just what have Apple and IBM gained from the much-ballyhooed partnership they announced last July? Well, since then, Apple and IBM have introduced 23 enterprise-focused...
JNJ: 100.43 (+0.13), MDT: 78.01 (+0.93), IBM: 165.36 (+1.10), AAPL: 128.62 (+1.71)
Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com
PRWeb - Tue Apr 21, 10:31AM CDT
The report "Dermatitis - Pipeline Review, H1 2015" provides comparative analysis on the therapeutic development for Dermatitis. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/dermatitis-p...eport.html .
VTAE: 14.04 (+0.02), FOMX: 10.94 (-0.02), PVCT: 0.90 (unch), JNJ: 100.43 (+0.13), DERM: 15.36 (-0.62), ANAC: 66.45 (-0.22), XNCR: 14.63 (-0.16), REGN: 472.63 (+9.41), AQXP: 7.91 (-0.41), BMY: 66.60 (-0.21), GSK: 46.57 (-0.67), VRX.TO: 253.14 (-6.24), CBPO: 99.67 (-0.84), MRK: 57.69 (+0.03), CCXI: 7.86 (-0.02), CLTX: 0.74 (-0.01), CELGZ: 2.87 (+0.04), NVS: 103.45 (-0.62)